SI
SI
discoversearch


 Biotech / Medical: Incyte Pharmaceuticals (INCY)  
Posts: 3026 | Member SubjectMarks: 143 | No Bans

Share This Board Moderated By: ANGELIQUE LEE -- (Not Moderated) -- Started: 1/21/1996 10:30:00 AM  Revision History

INCY 47.30+0.7%Apr 24 5:20 PM EDTNews
INCY is involved in the mapping of the human genome and is supported by many major pharmeceutical companies. I bought in at 28 as a long-term buy when they started trading on the NASDAQ last week. They ahve been moving quite a bit since then, breaking new highs at closing all week. Friday their day low was 30, day high of 36. Anybody have recent info that might explain the fluctuation? Thanks, Angelique
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
3026ditto, HER2-negative breast.... clinicaltrials.gov  Be interesting to seescaram(o)uche-04/23/2014 06:47 PM
3025>> And it _is_ rux's rolling rock, rather than 110's or 986's scaram(o)uche-04/23/2014 04:57 PM
3024As everyone here probably knows, title abstracts (minus late breakers) are out fscaram(o)uche-04/22/2014 11:41 AM
3023>> Gilead isn't letting cyt-387 moss grow under rux's rolling rockscaram(o)uche-04/21/2014 11:44 AM
3022#2 was first from this Zach guy, who is quite good, a week ago. So, my news is scaram(o)uche-04/09/2014 04:42 PM
3021Hey! Hope everyone is well/thriving! >> Not sure where I'd buy back scaram(o)uche-04/09/2014 09:04 AM
3020Top line results of ruxolitinib in PV; hits primary endpoint in P3: >>Martuck-04/08/2014 12:27 PM
3019On the INCY competition front... "Galapagos NV ( GLPGF) announced today thBiotech Jim-02/28/2014 07:52 AM
3018Probably a coincidence. Musings on MRK's MK-3475 deals announced today: inDewDiligence_on_SI-02/05/2014 01:41 PM
3017Noticed a concomitant movement of the release of this news and the dive of the sD.Lu-02/05/2014 12:23 PM
3016From Practice Update, an oncology journal updater that I subscribe to. The NatuBiotech Jim-01/28/2014 12:36 PM
3015Does anyone have any thoughts, input or info on the Ruxo Phase 2 PanCa subgroup,quantman-01/16/2014 10:58 PM
3014<Any speculation why Friedman resigned? He did present at JP Morgan.> LoBiotech Jim-01/14/2014 08:44 AM
3013Incyte announces the appointment of former Novartis Oncology president HervéD.Lu-01/14/2014 06:39 AM
3012Paul Friedman will present at JP Morgan Healthcare Conference on Monday, Jan 13D.Lu-01/02/2014 10:25 AM
3011>> a 093 plus ruxolitinib combo, lymphoma, seemed like a telegraphed next-scaram(o)uche-12/23/2013 12:07 PM
3010Fast, indeed, at 3 months. I gather that is as mature as their data gets at thituck-12/10/2013 03:19 PM
3009First, thanks for pointing me to that poster/graphic. Hadn't seen it, only scaram(o)uche-12/10/2013 03:01 PM
3008OK, thanks, but look at my edit. I gather you already found the Incyte results tuck-12/10/2013 02:55 PM
3007>> Geron's results don't seem to beat that << Yes, they do.scaram(o)uche-12/10/2013 02:46 PM
3006"An exploratory analysis of data collected over five years in the ongoing tuck-12/10/2013 02:40 PM
300518% reversal of marrow fibrosis, damn good but not as good as some expect/hope. scaram(o)uche-12/09/2013 06:25 PM
3004finance.yahoo.com  Jakafi® (ruxolitinib) Continues to Show Improved Oscaram(o)uche-12/09/2013 12:56 PM
3003>> early efficacy, panobinostat combo, to the presented at meeting <<scaram(o)uche-12/09/2013 12:50 PM
3002First shot of day fired against rux comes from pacritinib. Wording is rather discaram(o)uche-12/09/2013 11:39 AM
3001Looks pretty good, my view, IPI-145.... pbs.twimg.com  pbs.twimg.com scaram(o)uche-12/08/2013 02:28 PM
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2014 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.